查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829708

2025年全球血球比容测量设备市场报告

Hematocrit Test Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，血球比容测量设备市场规模强劲成长，从2024年的46.3亿美元增加至2025年的49.1亿美元，复合年增长率为6.0%。这段历史时期的成长归因于人们对贫血、铁和维生素缺乏症认识的不断提高、慢性病盛行率的上升、政府资金的激增以及人口的增长。

预计未来几年，血球比容测量设备市场规模将强劲成长，2029年将达到61.9亿美元，年复合成长率（CAGR）为6.0%。预测期内的增长归因于贫血盛行率的上升、血液疾病病例的增加、老年人口的增长、人们对健康和健身的日益关注以及对心血管诊断设备的需求的不断增长。预测期内的主要趋势包括尖端解决方案的引入、医疗技术的进步、高效创新新产品的研发、血球比容检测技术的进步以及医疗保健领域的进步。

血球比容测量仪是一种用于测量人体总血容量中红血球 (RBC) 百分比的医疗设备。此类设备用途广泛，包括慢性疾病监测、术前评估、血液兴奋剂检测、捐血筛检、紧急管理以及进行研究和临床试验。

血球比容测量设备的主要类型包括血球比容仪、血球比容测量分析仪以及试剂和耗材。血球比容仪 (HCT) 是一种用于测量全血中红血球百分比的照护现场设备。它们广泛应用于各种终端使用者环境，包括医院、门诊手术中心、诊所以及诊断和病理实验室，用于治疗贫血、真性红血球增多症和先天性心臟疾病等疾病。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供血细胞比容计量装置的市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的血细胞比容计量装置细分市场、市场趋势和商机，以及您在血细胞比容计量装置行业取得成功所需的数据。本血球比容计量装置市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

我们预测未来五年该市场将成长6.0%，较先前预测略有下降0.6%。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自墨西哥和巴西等主要地区的微量血细胞比容毛细管和高速离心机转子征收关税直接影响美国，从而导致贫血筛检下降，血液疾病诊断成本上升。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响可能会更加广泛。

预计血液疾病发生率的上升将在未来几年推动血球比容测量设备市场的扩张。血液疾病包括影响人体血液各种成分的疾病，例如红血球、白血球、血小板和血浆。由于遗传因素、环境污染和生活方式改变等多种因素，这些疾病变得越来越普遍。血球比容测量设备在测量全血中红血球的体积分数方面发挥关键作用，为了解患者的血液健康状况提供了重要的资讯。例如，美国癌症协会于 2024 年 1 月发布的一份报告预测，2024 年美国将新患者，估计死亡人数为 23,670 人。其中，预计新增急性骨髓性白血病(AML) 病例约 20,800 例，主要影响成年患者，约 11,220 人死于 AML。因此，血液疾病发生率的不断上升刺激了血球比容测量设备市场的成长。

血球容积比检测设备市场的主要企业正在创新提供血球定量和定性资讯的产品线，例如全血球计数 (CBC) 血液学分析仪。全血球计数 (CBC) 血液学分析仪是用于测量和分析各种血液成分的自动化仪器，包括红血球 (RBC)、白血球 (WBC) 和血小板。例如，2022 年 3 月，中国医疗设备公司迈瑞医疗国际有限公司推出了 BC-700 血液学分析仪系列。该系列涵盖全血球计数 (CBC) 和红血球沉积速率(ESR) 测试，专为中型实验室设计，其先进的诊断技术可与高级产品相媲美。 BC-700 系列包括 BC-720、BC-760 和 BC-780 等型号，是高端 BC-6000 系列的更紧凑版本，并配备了迈瑞的 SF-Cube 3D 分析技术。 SF Cube 技术利用萤光和双角度雷射散射讯号对目标细胞进行3D分析。

2023年6月，美国包装食品製造商玛氏公司（Mars, Incorporated）以13亿美元收购了赫斯卡公司（Heska Corporation）。此次收购后，赫斯卡成为玛氏宠物护理公司科学与诊断部门的一部分，扩大了其在诊断和技术领域的影响力。此次整合将加速研发，并提升全球宠物医疗保健解决方案的可近性。赫斯卡公司专注于製造血球容积比测量设备。

血球比容测量设备市场包括血球比容离心机、试纸、毛细管传输管和适配器套件的销售。该市场的价值是指“出厂价”，即商品製造商或创造者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场中的商品价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球血球比容测量设备：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球血球比容仪市场：成长率分析
  • 全球血球比容计量装置市场表现：规模与成长，2019-2024
  • 全球血球比容计量装置市场预测：规模与成长，2024-2029年，2034年
  • 全球血球比容测量设备：总目标市场（TAM）

第六章 市场细分

  • 全球血球比容测量设备市场：按产品、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 血球比容测定仪
  • 血球容积比检测仪
  • 试剂和耗材
  • 全球血球比容计量装置市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 贫血
  • 真性红血球增多症
  • 先天性心臟疾病
  • 其他用途
  • 全球血球比容测量设备市场：按最终用户、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院及门诊手术中心
  • 诊所
  • 诊断和病理实验室
  • 其他最终用户
  • 全球血球容积比测量设备市场：依血球容积比测试仪类型、表现与预测细分，2019-2024 年、2024-2029 年、2034 年
  • 手持式血球比容仪
  • 可携式血球容积比仪
  • 桌上型血球比容仪
  • 照护现场血球比容仪
  • 数位血球比容计
  • 电池供电的血球容积比仪
  • 全球血球比容测量设备市场：细分血球容积比测试设备（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 自动血球容积比分析仪
  • 桌上型血球比容分析仪
  • 半自动血球容积比分析仪
  • 微量血球容积比分析仪
  • 高通量血球容积比分析仪
  • 紧凑型血球比容分析仪
  • 全球血球比容计量装置市场：按试剂和耗材（按类型）细分，实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 血球测试纸
  • 血球比容移液管和毛细管
  • 用于血球容积比测试的血液检体采集管
  • 血球容积比检测品管试剂
  • 血球比容测量设备的校正标准
  • 一次性检测套组及耗材

第七章 区域和国家分析

  • 全球血球容积比测量设备市场：区域、现况及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球血球容积比测量设备市场：依国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 血球比容测量设备市场：竞争格局
  • 血球比容测量设备市场：公司简介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Danaher Corporation
  • Siemens Healthcare GmbH
  • Becton, Dickinson and Company（BD）
  • Terumo Corporation
  • Beckman Coulter Inc.
  • Mindray Medical International Limited
  • bioMerieux SA
  • Sysmex Corporation
  • Horiba Ltd.
  • Nihon Kohden Corporation
  • Erba Mannheim
  • Heska Corporation
  • EKF Diagnostics Holding Plc.
  • Nova Biomedical Corporation
  • Boule Diagnostics AB

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年血球容积比测量设备市场：提供新机会的国家
  • 2029 年血球容积比测量设备市场：细分市场带来新机会
  • 2029 年血球比容测量设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r30370u

Hematocrit test devices are medical instruments utilized to measure the percentage of red blood cells (RBCs) in a person's total blood volume. These devices serve various purposes, including monitoring chronic conditions, preoperative assessments, detecting blood doping, screening blood donors, managing emergencies, and conducting research and clinical trials.

The primary types of hematocrit test devices include hematocrit test meters, hematocrit test analyzers, and reagents and consumables. A hematocrit (HCT) test meter is a point-of-care device employed to measure the percentage of red blood cells in whole blood. It finds applications in conditions such as anemia, polycythemia vera, congenital heart diseases, among others, and is utilized by various end-users, including hospitals and ambulatory surgical centers, clinics, diagnostic and pathology labs, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The hematocrit test devices market research report is one of a series of new reports from The Business Research Company that provides hematocrit test devices market statistics, including hematocrit test devices industry global market size, regional shares, competitors with a hematocrit test devices market share, detailed hematocrit test devices market segments, market trends and opportunities, and any further data you may need to thrive in the hematocrit test devices industry. This hematocrit test devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hematocrit test devices market size has grown strongly in recent years. It will grow from $4.63 billion in 2024 to $4.91 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to a rise in awareness regarding anemia, lack of iron and vitamins, increased incidence of chronic illnesses, the surge in government funding, and increase in the population.

The hematocrit test devices market size is expected to see strong growth in the next few years. It will grow to $6.19 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing prevalence of anemia, growing cases of blood disorders, rise in geriatric population, growth in focus on health and fitness, and widening need for cardiovascular diagnostic equipment. Major trends in the forecast period include the introduction of cutting-edge solutions, advancement of technology in medical science, creation of new efficient and innovative products, technical developments in hematocrit testing, and advancements in the healthcare sector.

The forecast of 6.0% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on microhematocrit capillary tubes and high-speed centrifuge rotors, sourced from key regions such as Mexico and Brazil, which could lead to compromised anemia screening and increased costs for blood disorder diagnostics.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing instances of blood disorders are anticipated to drive the expansion of the hematocrit test devices market in the coming years. Blood disorders encompass conditions affecting the various components of human blood, such as red blood cells, white blood cells, platelets, and plasma. These disorders are becoming more prevalent due to a combination of factors including genetic factors, environmental pollution, and changes in lifestyle. Hematocrit test devices play a vital role in measuring the volume percentage of red blood cells in whole blood, offering essential insights into the patient's hematological well-being. For example, a report published by the American Cancer Society in January 2024 projects approximately 62,770 new cases of leukemia in the United States for 2024, leading to an estimated 23,670 deaths. Among these cases, around 20,800 new instances of acute myeloid leukemia (AML) are expected, predominantly affecting adults, with approximately 11,220 deaths attributed to AML, primarily occurring in adult patients. Thus, the rising occurrences of blood disorders are stimulating the growth of the hematocrit test devices market.

Leading companies in the hematocrit test device market are innovating their product offerings, such as complete blood count (CBC) hematology analyzers, to deliver both quantitative and qualitative information about blood cells. A complete blood count (CBC) hematology analyzer is an automated instrument utilized to measure and analyze various components of blood, including red blood cells (RBCs), white blood cells (WBCs), and platelets. For instance, in March 2022, Mindray Medical International Limited, a China-based medical device company, introduced the BC-700 hematology analyzer series. This series encompasses both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests, catering to medium-volume laboratories with advanced diagnostic technologies akin to premium products. The BC-700 Series, including models such as BC-720, BC-760, and BC-780, is a more compact iteration of the high-end BC-6000 Series, featuring Mindray's SF Cube 3D analysis technology. Leveraging fluorescence and bi-angular laser scatter signals, the SF Cube technology enables three-dimensional analysis of target cells.

In June 2023, Mars Incorporated, a US-based packaged food products manufacturer, acquired Heska Corporation for $1.3 billion. With this acquisition, Heska now operates under Mars Petcare's Science & Diagnostics division, expanding its reach in diagnostics and technology. The integration facilitates accelerated research and development efforts while enhancing global access to pet healthcare solutions. Heska Corporation specializes in manufacturing hematocrit test devices.

Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton, Dickinson and Company (BD), Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMerieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, Heska Corporation, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory Lp, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.

North America was the largest region in the hematocrit test devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hematocrit test devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hematocrit test devices market consists of sales of hematocrit centrifuges, test strips, capillary transfer tubes, and adapter kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hematocrit Test Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hematocrit test devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hematocrit test devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hematocrit test devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Hematocrit Test Meter; Hematocrit Test Analyzer; Reagents And Consumables
  • 2) By Application: Anemia; Polycythemia Vera; Congenital Heart Diseases; Other Applications
  • 3) By End-User: Hospitals And Ambulatory Surgical Centers; Clinics; Diagnostic And Pathology Labs; Other End-Users
  • Subsegments:
  • 1) By Hematocrit Test Meter: Handheld Hematocrit Meters; Portable Hematocrit Meters; Desktop Hematocrit Meters; Point-Of-Care Hematocrit Meters; Digital Hematocrit Meters; Battery-Powered Hematocrit Meters
  • 2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers; Benchtop Hematocrit Analyzers; Semi-Automated Hematocrit Analyzers; Microhematocrit Analyzers; High-Throughput Hematocrit Analyzers; Compact Hematocrit Analyzers
  • 3) By Reagents And Consumables: Hematocrit Test Strips; Hematocrit Pipettes And Capillaries; Blood Sample Collection Tubes For Hematocrit Testing; Quality Control Reagents For Hematocrit Testing; Calibration Standards For Hematocrit Devices; Disposable Test Kits And Consumables
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthcare GmbH; Becton, Dickinson and Company (BD); Terumo Corporation; Beckman Coulter Inc.; Mindray Medical International Limited; bioMerieux SA; Sysmex Corporation; Horiba Ltd.; Nihon Kohden Corporation; Erba Mannheim; Heska Corporation; EKF Diagnostics Holding Plc.; Nova Biomedical Corporation; Boule Diagnostics AB; Stanbio Laboratory Lp; Drucker Diagnostics; A. Menarini Diagnostics Srl; Sensa Core; Mikroscan Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hematocrit Test Devices Market Characteristics

3. Hematocrit Test Devices Market Trends And Strategies

4. Hematocrit Test Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hematocrit Test Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hematocrit Test Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hematocrit Test Devices Market Growth Rate Analysis
  • 5.4. Global Hematocrit Test Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hematocrit Test Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hematocrit Test Devices Total Addressable Market (TAM)

6. Hematocrit Test Devices Market Segmentation

  • 6.1. Global Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hematocrit Test Meter
  • Hematocrit Test Analyzer
  • Reagents And Consumables
  • 6.2. Global Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Anemia
  • Polycythemia Vera
  • Congenital Heart Diseases
  • Other Applications
  • 6.3. Global Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Ambulatory Surgical Centers
  • Clinics
  • Diagnostic And Pathology Labs
  • Other End-Users
  • 6.4. Global Hematocrit Test Devices Market, Sub-Segmentation Of Hematocrit Test Meter, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Handheld Hematocrit Meters
  • Portable Hematocrit Meters
  • Desktop Hematocrit Meters
  • Point-Of-Care Hematocrit Meters
  • Digital Hematocrit Meters
  • Battery-Powered Hematocrit Meters
  • 6.5. Global Hematocrit Test Devices Market, Sub-Segmentation Of Hematocrit Test Analyzer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Hematocrit Analyzers
  • Benchtop Hematocrit Analyzers
  • Semi-Automated Hematocrit Analyzers
  • Microhematocrit Analyzers
  • High-Throughput Hematocrit Analyzers
  • Compact Hematocrit Analyzers
  • 6.6. Global Hematocrit Test Devices Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hematocrit Test Strips
  • Hematocrit Pipettes And Capillaries
  • Blood Sample Collection Tubes For Hematocrit Testing
  • Quality Control Reagents For Hematocrit Testing
  • Calibration Standards For Hematocrit Devices
  • Disposable Test Kits And Consumables

7. Hematocrit Test Devices Market Regional And Country Analysis

  • 7.1. Global Hematocrit Test Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hematocrit Test Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hematocrit Test Devices Market

  • 8.1. Asia-Pacific Hematocrit Test Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hematocrit Test Devices Market

  • 9.1. China Hematocrit Test Devices Market Overview
  • 9.2. China Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hematocrit Test Devices Market

  • 10.1. India Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hematocrit Test Devices Market

  • 11.1. Japan Hematocrit Test Devices Market Overview
  • 11.2. Japan Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hematocrit Test Devices Market

  • 12.1. Australia Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hematocrit Test Devices Market

  • 13.1. Indonesia Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hematocrit Test Devices Market

  • 14.1. South Korea Hematocrit Test Devices Market Overview
  • 14.2. South Korea Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hematocrit Test Devices Market

  • 15.1. Western Europe Hematocrit Test Devices Market Overview
  • 15.2. Western Europe Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hematocrit Test Devices Market

  • 16.1. UK Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hematocrit Test Devices Market

  • 17.1. Germany Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hematocrit Test Devices Market

  • 18.1. France Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hematocrit Test Devices Market

  • 19.1. Italy Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hematocrit Test Devices Market

  • 20.1. Spain Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hematocrit Test Devices Market

  • 21.1. Eastern Europe Hematocrit Test Devices Market Overview
  • 21.2. Eastern Europe Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hematocrit Test Devices Market

  • 22.1. Russia Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hematocrit Test Devices Market

  • 23.1. North America Hematocrit Test Devices Market Overview
  • 23.2. North America Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hematocrit Test Devices Market

  • 24.1. USA Hematocrit Test Devices Market Overview
  • 24.2. USA Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hematocrit Test Devices Market

  • 25.1. Canada Hematocrit Test Devices Market Overview
  • 25.2. Canada Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hematocrit Test Devices Market

  • 26.1. South America Hematocrit Test Devices Market Overview
  • 26.2. South America Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hematocrit Test Devices Market

  • 27.1. Brazil Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hematocrit Test Devices Market

  • 28.1. Middle East Hematocrit Test Devices Market Overview
  • 28.2. Middle East Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hematocrit Test Devices Market

  • 29.1. Africa Hematocrit Test Devices Market Overview
  • 29.2. Africa Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hematocrit Test Devices Market Competitive Landscape And Company Profiles

  • 30.1. Hematocrit Test Devices Market Competitive Landscape
  • 30.2. Hematocrit Test Devices Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Hematocrit Test Devices Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. Siemens Healthcare GmbH
  • 31.3. Becton, Dickinson and Company (BD)
  • 31.4. Terumo Corporation
  • 31.5. Beckman Coulter Inc.
  • 31.6. Mindray Medical International Limited
  • 31.7. bioMerieux SA
  • 31.8. Sysmex Corporation
  • 31.9. Horiba Ltd.
  • 31.10. Nihon Kohden Corporation
  • 31.11. Erba Mannheim
  • 31.12. Heska Corporation
  • 31.13. EKF Diagnostics Holding Plc.
  • 31.14. Nova Biomedical Corporation
  • 31.15. Boule Diagnostics AB

32. Global Hematocrit Test Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hematocrit Test Devices Market

34. Recent Developments In The Hematocrit Test Devices Market

35. Hematocrit Test Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Hematocrit Test Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hematocrit Test Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hematocrit Test Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer